Employers are suspicious about the lack of transparency in setting drug prices, and wary about what they perceive as their overdependence on PBMs in setting those prices. (Image: Shutterstock)
A new report sheds light on possible strategies for holding down drug costs for enrollees of employer health plans. Addressing perceived waste and lack of transparency around the practices of pharmacy benefit managers (PBMs) top the list, according to the study.
The report, by the National Alliance of Healthcare Purchaser Coalitions (National Alliance), used surveys and roundtables to take the pulse of more than 80 employers of different sizes from across the country.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
